🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy and safety of simple...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2019-11-01
Trial ID
NCT04204577
Treatments Being Tested
Patients with previously untreated advanced or metastatic esophageal squamo...
Status
Unknown
Location
Jing Huang
Start Date
2018-07-31
Trial ID
NCT03603756
Treatments Being Tested
To observe the effectiveness of SHR-1210 (Camrelizumab) combined with apati...
Status
Unknown
Location
Tianjin Medical University Cancer Hospital & Institute
Start Date
2019-06-01
Trial ID
NCT04126993
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Apatini...
Status
Unknown
Location
Zhongnan Hopital of Wuhan University
Start Date
2021-05-14
Trial ID
NCT04781686
Treatments Being Tested
Apatinib and SHR-1210 are new drugs produced by jiangsu hengrui pharmaceuti...
Status
Unknown
Location
Beijing Hospital
Start Date
2021-03-25
Trial ID
NCT04832204
Treatments Being Tested
SABRE STUDY will explore effectiveness and safety of the combination therap...
Status
Unknown
Location
Zhongnan Hospital of Wuhan University
Start Date
2022-03-15
Trial ID
NCT04878107
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Multiple Locations
Start Date
2021-12-05
Trial ID
NCT05049681
Treatments Being Tested
The aim of this study was to investigate the safety and efficacy of SHR-121...
Status
Unknown
Location
Sichuan Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT04133337
This study is to evaluate the tolerance of albumin paclitaxel combined with...
Status
Unknown
Location
The First Hospital of China Medical University
Start Date
2020-03
Trial ID
NCT04286711
Treatments Being Tested
This is a Phase II , Open-label , Investigator-initiated Trail of SHR-1210 ...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-12-01
Trial ID
NCT04297202
Treatments Being Tested